17-Hydroxypregnenolone Quantitative by LC-MS/MS, Serum or Plasma
Ordering Recommendation
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
1-4 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
Serum separator tube. Also acceptable: Plain red, lavender (EDTA), pink (K2EDTA), or green (sodium or lithium heparin). 
Specimen Preparation
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer two 0.5 mL serum or plasma specimens to an ARUP Standard Transport Tube and freeze immediately. (Min: 0.25 mL/container) 
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. 
Unacceptable Conditions
Refrigerated or room temperature specimens. 
After separation from cells: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 6 months 
Reference Interval
Premature (26-28 weeks)1219-9799 ng/dL1219-9799 ng/dL
Premature (29-36 weeks)346-8911 ng/dL346-8911 ng/dL
Full Term (1-5 months)229-3104 ng/dL229-3104 ng/dL
6-12 monthsless than or equal to 917ng/dLless than or equal to 917ng/dL
13-23 monthsless than or equal to 592 ng/dLless than or equal to 592 ng/dL
2-4 yearsless than or equal to 280 ng/dLless than or equal to 249 ng/dL
5-6 yearsless than or equal to 350 ng/dLless than or equal to 319 ng/dL
7-9 yearsless than or equal to 212 ng/dLless than or equal to 187 ng/dL
10-12 yearsless than or equal to 398 ng/dLless than or equal to 392 ng/dL
13-15 yearsless than or equal to 407 ng/dL35-465 ng/dL
16-17 yearsless than or equal to 423 ng/dL32-478 ng/dL
18 years and olderLess than 226 ng/dLLess than 442 ng/dL
Tanner Stage Iless than or equal to 235 ng/dLless than or equal to 208 ng/dL
Tanner Stage IIless than or equal to 367 ng/dLless than or equal to 355 ng/dL
Tanner Stage IIIless than or equal to 430 ng/dLless than or equal to 450 ng/dL
Tanner Stage IV-Vless than or equal to 412 ng/dL35-478 ng/dL

Interpretive Data

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Component Test Code*Component Chart NameLOINC
009233317-Hydroxypregnenolone Quant, MS/MS, Ser6765-2
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.